DTIL
$1.71
Precision Biosciences
($.02)
(1.16%)
DTIL
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus:  ($0.43)
Revenue:  $5.01 Mil
Monday
Aug 8
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when DTIL reports earnings?
Beat
Meet
Miss

Where is DTIL's stock price going from here?
Up
Flat
Down
Stock chart of DTIL
Analysts
Summary of analysts' recommendations for DTIL
Score
Grade
Pivots
Resistance
$2.05
$1.92
$1.82

$1.69

Support
$1.59
$1.46
$1.36
Tweet
Growth
Description
Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.